Header Logo

Connection

ARNOLD DELA CRUZ PAULINO to Medulloblastoma

Back to Details
This is a "connection" page, showing publications ARNOLD DELA CRUZ PAULINO has written about Medulloblastoma.
ARNOLD DELA CRUZ PAULINO
Connection Strength
8.278
Medulloblastoma
  1. The cochlear dose and the age at radiotherapy predict severe hearing loss after passive scattering proton therapy and cisplatin in children with medulloblastoma. Neuro Oncol. 2024 Oct 03; 26(10):1912-1920.
    View in: PubMed
    Score: 0.646
  2. Late-onset lymphopenia during radiation is associated with an increased risk of tumor recurrence in newly diagnosed pediatric medulloblastoma. Pediatr Blood Cancer. 2024 Jul; 71(7):e31022.
    View in: PubMed
    Score: 0.626
  3. Late Effects of Craniospinal Irradiation Using Electron Spinal Fields for Pediatric Patients With Cancer. Int J Radiat Oncol Biol Phys. 2023 01 01; 115(1):164-173.
    View in: PubMed
    Score: 0.551
  4. Overall survival and secondary malignant neoplasms in children receiving passively scattered proton or photon craniospinal irradiation for medulloblastoma. Cancer. 2021 Oct 15; 127(20):3865-3871.
    View in: PubMed
    Score: 0.517
  5. Scoliosis in Children Treated With Photon Craniospinal Irradiation for Medulloblastoma. Int J Radiat Oncol Biol Phys. 2021 03 01; 109(3):712-717.
    View in: PubMed
    Score: 0.504
  6. Meta-analysis of the incidence and patterns of second neoplasms after photon craniospinal irradiation in children with medulloblastoma. Pediatr Blood Cancer. 2018 08; 65(8):e27095.
    View in: PubMed
    Score: 0.413
  7. Ototoxicity and cochlear sparing in children with medulloblastoma: Proton vs. photon radiotherapy. Radiother Oncol. 2018 07; 128(1):128-132.
    View in: PubMed
    Score: 0.406
  8. Radiotherapy Deferral in Medulloblastoma. JAMA Oncol. 2016 Dec 01; 2(12):1582.
    View in: PubMed
    Score: 0.375
  9. Comparison of supine and prone craniospinal irradiation in children with medulloblastoma. Pract Radiat Oncol. 2015 Mar-Apr; 5(2):93-8.
    View in: PubMed
    Score: 0.317
  10. Secondary glioblastoma multiform in a patient with CHARGE syndrome and prior radiation therapy for medulloblastoma. Pediatr Hematol Oncol. 2014 May; 31(4):366-8.
    View in: PubMed
    Score: 0.312
  11. Local control after craniospinal irradiation, intensity-modulated radiotherapy boost, and chemotherapy in childhood medulloblastoma. Cancer. 2011 Feb 01; 117(3):635-41.
    View in: PubMed
    Score: 0.244
  12. Ototoxicity after intensity-modulated radiation therapy and cisplatin-based chemotherapy in children with medulloblastoma. Int J Radiat Oncol Biol Phys. 2010 Dec 01; 78(5):1445-50.
    View in: PubMed
    Score: 0.236
  13. Prognostic factors after extraneural metastasis of medulloblastoma. Int J Radiat Oncol Biol Phys. 2010 Sep 01; 78(1):72-8.
    View in: PubMed
    Score: 0.234
  14. Treatment of brain tumors. N Engl J Med. 2005 Jun 02; 352(22):2350-3; author reply 2350-3.
    View in: PubMed
    Score: 0.169
  15. Long-term survival in a child with extraneural metastasis from medulloblastoma treated with chemo-radiotherapy. Med Pediatr Oncol. 2003 Jun; 40(6):396-7.
    View in: PubMed
    Score: 0.147
  16. Resection cavity auto-contouring for patients with pediatric medulloblastoma using only CT information. J Appl Clin Med Phys. 2023 Jul; 24(7):e13956.
    View in: PubMed
    Score: 0.145
  17. Protracted radiotherapy treatment duration in medulloblastoma. Am J Clin Oncol. 2003 Feb; 26(1):55-9.
    View in: PubMed
    Score: 0.144
  18. Automating the treatment planning process for 3D-conformal pediatric craniospinal irradiation therapy. Pediatr Blood Cancer. 2023 03; 70(3):e30164.
    View in: PubMed
    Score: 0.143
  19. Current multimodality management of medulloblastoma. Curr Probl Cancer. 2002 Nov-Dec; 26(6):317-56.
    View in: PubMed
    Score: 0.141
  20. Hypothyroidism in children with medulloblastoma: a comparison of 3600 and 2340 cGy craniospinal radiotherapy. Int J Radiat Oncol Biol Phys. 2002 Jul 01; 53(3):543-7.
    View in: PubMed
    Score: 0.138
  21. Variation in Proton Craniospinal Irradiation Practice Patterns in the United States: A Pediatric Proton Consortium Registry (PPCR) Study. Int J Radiat Oncol Biol Phys. 2022 03 15; 112(4):901-912.
    View in: PubMed
    Score: 0.132
  22. Comparison of hypothyroidism, growth hormone deficiency, and adrenal insufficiency following proton and photon radiotherapy in children with medulloblastoma. J Neurooncol. 2021 Oct; 155(1):93-100.
    View in: PubMed
    Score: 0.131
  23. Observed-to-expected incidence ratios of second malignant neoplasms after radiation therapy for medulloblastoma: A Surveillance, Epidemiology, and End Results analysis. Cancer. 2021 07 01; 127(13):2368-2375.
    View in: PubMed
    Score: 0.126
  24. Clinical Outcomes and Patient-Matched Molecular Composition of Relapsed Medulloblastoma. J Clin Oncol. 2021 03 01; 39(7):807-821.
    View in: PubMed
    Score: 0.125
  25. Comparison of posterior fossa and tumor bed boost in medulloblastoma. Am J Clin Oncol. 2000 Oct; 23(5):487-90.
    View in: PubMed
    Score: 0.122
  26. Development of second primary tumors and outcomes in medulloblastoma by treatment modality: A Surveillance, Epidemiology, and End Results analysis. Pediatr Blood Cancer. 2020 08; 67(8):e28373.
    View in: PubMed
    Score: 0.119
  27. Reply to S.A. Milgrom et al. J Clin Oncol. 2020 07 01; 38(19):2212-2213.
    View in: PubMed
    Score: 0.119
  28. Posterior fossa boost in medulloblastoma: an analysis of dose to surrounding structures using 3-dimensional (conformal) radiotherapy. Int J Radiat Oncol Biol Phys. 2000 Jan 15; 46(2):281-6.
    View in: PubMed
    Score: 0.116
  29. Superior Intellectual Outcomes After Proton Radiotherapy Compared With Photon Radiotherapy for Pediatric Medulloblastoma. J Clin Oncol. 2020 02 10; 38(5):454-461.
    View in: PubMed
    Score: 0.115
  30. Medulloblastoma and supratentorial primitive neuroectodermal tumors: an institutional experience. Cancer. 1999 Jul 01; 86(1):142-8.
    View in: PubMed
    Score: 0.112
  31. The cranial-spinal junction in medulloblastoma: does it matter? Int J Radiat Oncol Biol Phys. 1999 Apr 01; 44(1):81-4.
    View in: PubMed
    Score: 0.110
  32. Hypothyroidism after craniospinal irradiation with proton or photon therapy in patients with medulloblastoma. Pediatr Hematol Oncol. 2018 May; 35(4):257-267.
    View in: PubMed
    Score: 0.108
  33. Radiotherapeutic management of medulloblastoma. Oncology (Williston Park). 1997 Jun; 11(6):813-23; discussion 823, 827-8, 831.
    View in: PubMed
    Score: 0.097
  34. The influence of pretreatment characteristics and radiotherapy parameters on time interval to development of radiation-associated meningioma. Int J Radiat Oncol Biol Phys. 2009 Dec 01; 75(5):1408-14.
    View in: PubMed
    Score: 0.055
  35. Changes mimicking new leptomeningeal disease after intensity-modulated radiotherapy for medulloblastoma. Int J Radiat Oncol Biol Phys. 2009 Jan 01; 73(1):214-21.
    View in: PubMed
    Score: 0.052
  36. Supine craniospinal irradiation using intrafractional junction shifts and field-in-field dose shaping: early experience at Methodist Hospital. Int J Radiat Oncol Biol Phys. 2008 Jun 01; 71(2):477-83.
    View in: PubMed
    Score: 0.051
  37. What is the best adjuvant treatment for very young patients with medulloblastoma? Expert Rev Neurother. 2007 Apr; 7(4):373-81.
    View in: PubMed
    Score: 0.048
  38. Brain and Brain Stem Necrosis After Reirradiation for Recurrent Childhood Primary Central Nervous System Tumors: A PENTEC Comprehensive Review. Int J Radiat Oncol Biol Phys. 2024 Jun 01; 119(2):655-668.
    View in: PubMed
    Score: 0.039
  39. The effect of an extended source-to-skin distance in the treatment of the spinal field in children receiving craniospinal irradiation. Med Dosim. 2004; 29(1):7-10.
    View in: PubMed
    Score: 0.038
  40. An open invitation to join the Pediatric Proton/Photon Consortium Registry to standardize data collection in pediatric radiation oncology. Br J Radiol. 2020 Mar; 93(1107):20190673.
    View in: PubMed
    Score: 0.029
  41. Determination of the inferior border of the thecal sac using magnetic resonance imaging: implications on radiation therapy treatment planning. Int J Radiat Oncol Biol Phys. 1998 Jun 01; 41(3):621-4.
    View in: PubMed
    Score: 0.026
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.